Related Experiment Video
Updated: Jul 29, 2025
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
1.9K
Recurrent malignant peritoneal mesothelioma treated by a second resection: A case report
Takashi Miyata1, Hisashi Nishiki1, Yuki Shinden1
1Department of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Clinical Case Reports
|May 22, 2023
Summary
Malignant peritoneal mesothelioma (MPM) is a rare cancer. Aggressive surgical treatment for primary and recurrent MPM can lead to long-term survival, even after multiple operations.
Area of Science:
- Oncology
- Surgical Oncology
- Abdominal Surgery
Background:
- Malignant peritoneal mesothelioma (MPM) is a rare and aggressive neoplasm.
- Surgical intervention for MPM, particularly for recurrent disease, is infrequently performed.
- Optimal treatment strategies for long-term survival remain under investigation.
Observation:
- This report details a rare case of a patient diagnosed with malignant peritoneal mesothelioma.
- The patient underwent two surgical procedures over a 4-year period for MPM.
- Despite the rarity and aggressive nature of the disease, the patient achieved long-term survival.
Findings:
- Aggressive surgical management, including for recurrent disease, can be a viable option for select MPM patients.
- Early diagnosis and prompt surgical intervention are crucial for improving outcomes.
- This case demonstrates the potential for long-term survival following multi-stage surgical treatment of MPM.
Implications:
- This case highlights the importance of considering aggressive surgical approaches for malignant peritoneal mesothelioma.
- Further research into the role of surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for MPM is warranted.
- Aggressive treatment paradigms may offer improved survival benefits for patients with this rare malignancy.
